IAVI, a nonprofit research organization, has entered a strategic alliance with Cairo-based biosimilars manufacturer Minapharm and Berlin-based contract development and manufacturing firm ProBioGen to expand vaccine and biologics production in Africa. The partnership aims to address the continent’s limited vaccine output—currently estimated at just 1% of its needs—by strengthening local innovation and manufacturing capabilities. The initiative will focus initially on developing a vaccine for M...